Medical Devices
Healthcare
Medical

BioTelemetry

$65.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.06 (1.65%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell BioTelemetry and other stocks, options, ETFs, and crypto commission-free!

About

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. Read More It operates through two segments: Healthcare and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.

Employees
1,500
Headquarters
Malvern, Pennsylvania
Founded
2013
Market Cap
2.14B
Price-Earnings Ratio
54.41
Dividend Yield
0.00
Average Volume
487.68K
High Today
$65.60
Low Today
$63.11
Open Price
$64.07
Volume
198.48K
52 Week High
$80.92
52 Week Low
$29.85

Collections

Medical Devices
Healthcare
Medical
Health
Health And Wellness
Technology
Wireless
Manufacturing

News

Yahoo FinanceMar 21

BioTelemetry (BEAT) Gains But Lags Market: What You Should Know

BioTelemetry (BEAT) closed the most recent trading day at $68.46, moving +0.87% from the previous trading session. BioTelemetry (BEAT) closed at $68.46 in the latest trading session, marking a +0.87% move from the prior day. The stock lagged the S&P 500's daily gain of 1.09%. Meanwhile, the Dow gained 0.84%, and the Nasdaq, a tech-heavy index, added 1.42%. Coming into today, shares of the heart monitoring device maker had lost 9.96% in the past month. In that same time, the Medical sector gained 1.58%, wh...

128
TradingNewsNowMar 21

Present Technicals: BioTelemetry (NASDAQ: BEAT)

BioTelemetry trades as part of the healthcare sector and is in the medical diagnostics and research industry. The company CEO is Joseph H. Capper. BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing and centralized core laboratory services for clinical research. Previous Intraday Trading Performance: The BEAT stock showed a previous change of -1.32% with an open at 68.74 and a close of 67.87. It reached an intraday h...

48
Seeking AlphaMar 13

iRhythm Technologies, Inc.: Growth Reversal Will Leave Investors Heartbroken

The TAM for the Zio is much smaller than iRhythm suggests, and the effort to expand its product offering through the Zio AT has been a failure.

100

Earnings

$0.16
$0.29
$0.43
$0.56
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 24, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.